Potential effect of virus interference on influenza vaccine effectiveness estimates in test-negative designs

Epidemiology and Infection

Volumn 142, Issue 12, 2014, Pages 2642-2646

  Suzuki, M ^a   Camacho, A ^b   Ariyoshi, K ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Influenza vaccine effectiveness; non influenza respiratory virus; test negative design; virus interference

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFICACY; IMMUNITY; INFECTION RATE; PANDEMIC; SEASON; SIMULATION; STATISTICAL MODEL; STUDY DESIGN; SYSTEMATIC ERROR; TEST NEGATIVE DESIGN; VIRUS INTERFERENCE; COMPUTER SIMULATION; EPIDEMIC; HUMAN; IMMUNOLOGY; INFLUENZA, HUMAN; TREATMENT OUTCOME; VIROLOGY;

COMPUTER SIMULATION; DISEASE OUTBREAKS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; TREATMENT OUTCOME; VIRAL INTERFERENCE;

EID: 84911461864     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268814000107     Document Type: Article

References (16)

1. Orenstein EW, et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. International Journal of Epidemiology 2007; 36: 623-631.
2. Jackson ML, Nelson JC. The test-negative design for estimating influenza vaccine effectiveness. Vaccine 2013; 31: 2165-2168.
3. De Serres GSD, Wu XW, Ambrose CS. The testnegative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials. Eurosurveillance 2013; 18(37): pii=20585.
4. Foppa IM, et al. The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine 2013; 31: 3104-3109.
5. Kelly H, et al. Seasonal influenza vaccination and the risk of infection with pandemic influenza: a possible illustration of non-specific temporary immunity following infection. Eurosurveillance 2010; 15(47).
6. Cowling BJ, Nishiura H. Virus interference and estimates of influenza vaccine effectiveness from testnegative studies. Epidemiology 2012; 23: 930-931.
7. Cowling BJ, et al. Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine. Clinical Infectious Diseases 2012; 54: 1778-1783.
8. Kelly H, et al. Vaccine effectiveness against laboratoryconfirmed influenza in healthy young children: a casecontrol study. Pediatric Infectious Disease Journal 2011; 30: 107-111.
9. Sundaram ME, et al. Influenza vaccination is not associated with detection of non-influenza respiratory viruses in seasonal studies of influenza vaccine effectiveness. Clinical Infectious Diseases 2013; 57: 789-793.
10. Skowronski DM, et al. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during spring-summer 2009: four observational studies from Canada. PLoS Medicine 2010; 7: e1000258.
11. Cox NJ, Subbarao K. Global epidemiology of influenza: past and present. Annual Review of Medicine 2000; 51: 407-421.
12. Wu JT, et al. Estimating infection attack rates and severity in real time during an influenza pandemic: analysis of serial cross-sectional serologic surveillance data. PLoS Medicine 2011; 8: e1001103.
13. Osterholm MT, et al. Efficacy and effectiveness of influenza vaccines: a systematic review and metaanalysis. Lancet Infectious Diseases 2012; 12: 36-44.
14. Yin JK, et al. Impacts on influenza A(H1N1)pdm09 infection from cross-protection of seasonal trivalent influenza vaccines and A(H1N1)pdm09 vaccines: systematic review and meta-analyses. Vaccine 2012; 30: 3209-3222.
15. Anestad G. Interference between outbreaks of respiratory syncytial virus and influenza virus infection. Lancet 1982; 1: 502.
16. Linde A, et al. Does viral interference affect spread of influenza? Eurosurveillance 2009; 14(40).